Ypsomed
Stefan Lindegger is an experienced engineering professional with a focus on innovation and software development in the medical technology sector. Currently serving as a Lead Innovation Engineer and previously as an Embedded Software Engineer at Ypsomed AG since August 2012, Stefan specializes in the architecture, detailed design, and implementation of device software. Prior to this role, Stefan held the position of Technical Leader in Product Development at Roche Diagnostics from 2000 to November 2012. Stefan holds a Nachdiplomstudium in Software Engineering from Berner Fachhochschule, completed between 2005 and 2007, and a Diploma in Electrical Engineering from HTA-BE Hochschule für Technik und Architektur Bern, obtained from 1997 to 1999.
This person is not in any teams
This person is not in any offices
Ypsomed
4 followers
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.